Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,126 | -33,350 | 11,322 | 16,528 | -59,995 |
| Depreciation Amortization | 11,305 | 8,327 | 5,886 | 2,951 | 10,033 |
| Accounts receivable | -5,983 | 2,744 | -4,006 | -615 | 2,353 |
| Accounts payable and accrued liabilities | -902 | 7,971 | -910 | -1,422 | -7,107 |
| Other Working Capital | -1,309 | 15,581 | -24,720 | -9,678 | 13,160 |
| Other Operating Activity | 46,665 | 24,812 | 28,015 | 7,897 | 42,329 |
| Operating Cash Flow | $20,650 | $26,085 | $15,587 | $15,661 | $773 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -46 |
| Purchase Of Investment | -38,073 | -38,073 | -19,117 | -10,696 | -29,826 |
| Sale Of Investment | 27,192 | 22,571 | 8,085 | 5,395 | 73,275 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -10,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10,000 |
| Investing Cash Flow | $-10,881 | $-15,502 | $-11,032 | $-5,301 | $33,403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 98,500 | 98,500 | N/A | N/A | 8,444 |
| Debt Repayment | -100,000 | -100,000 | N/A | N/A | -8,444 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 68 |
| Other Financing Activity | -30,431 | -30,429 | 0 | 0 | -10,000 |
| Financing Cash Flow | $-31,931 | $-31,929 | $N/A | $N/A | $-9,932 |
| Beginning Cash Position | 97,454 | 97,454 | 97,454 | 97,454 | 73,210 |
| End Cash Position | 75,292 | 76,108 | 102,009 | 107,814 | 97,454 |
| Net Cash Flow | $-22,162 | $-21,346 | $4,555 | $10,360 | $24,244 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,650 | 26,085 | 15,587 | 15,661 | 773 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -46 |
| Free Cash Flow | 20,650 | 26,085 | 15,587 | 15,661 | 727 |